MarketCap
Facebook
X
Telegram
Country |
 USA |
IPO year |
2000 |
Industry |
Diagnostics research |
Stock Exchange |
NASDAQ GLOBALSPB |
Shares |
155 M |
Market Cap[1] |
$ 35.1 B |
EBITDA (LTM) |
$ 1.08 B |
P/E (LTM) |
43.367459 |
P/S (LTM) |
8.466291 |
EPS (LTM) |
5.47 |
Other stocks of industry "Diagnostics research"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
 |
Fluidigm Corporation
FLDM
|
- | 1.08 % | $ 308 M | Nasdaq Global Select Market | USA |
 |
ICON Public Limited Company
ICLR
|
$ 202.93 | -0.41 % | $ 15.9 B | Nasdaq Global Select Market,SPB |  Irlanda |
 |
IDEXX Laboratories
IDXX
|
$ 699.65 | 4.11 % | $ 56.3 B | Nasdaq Global Select Market,SPB | USA |
 |
Co-Diagnostics
CODX
|
$ 0.36 | -4.71 % | $ 479 K | Nasdaq Capital Market | USA |
 |
IQVIA Holdings
IQV
|
$ 266.45 | 1.47 % | $ 45.8 B | NYSE,SPB | USA |
 |
Burning Rock Biotech Limited
BNR
|
$ 12.77 | 16.73 % | $ 134 M | Nasdaq Global Market |  China |
 |
PRA Health Sciences, Inc.
PRAH
|
- | - | $ 10.7 B | Nasdaq Global Select Market | USA |
 |
DarioHealth Corp.
DRIO
|
$ 2.96 | -1.33 % | $ 11.8 M | Nasdaq Capital Market |  Israel |
 |
Natera
NTRA
|
$ 390.37 | 0.45 % | $ 53.4 B | Nasdaq Global Select Market,SPB | USA |
 |
Koninklijke Philips N.V.
PHG
|
$ 31.09 | 9.24 % | $ 29.5 B | NYSE |  Niderland |
 |
Myriad Genetics
MYGN
|
$ 6.01 | -0.58 % | $ 557 M | Nasdaq Global Select Market,SPB | USA |
 |
ENDRA Life Sciences
NDRA
|
$ 4.96 | 2.06 % | $ 3.9 M | Nasdaq Global Select Market | USA |
 |
NeoGenomics
NEO
|
$ 17.11 | 1.66 % | $ 2.19 B | Nasdaq Global Select Market,SPB | USA |
 |
OPKO Health
OPK
|
$ 1.79 | 4.07 % | $ 1.34 B | Nasdaq Global Select Market | USA |
 |
Pacific Biosciences of California
PACB
|
$ 2.51 | 2.66 % | $ 753 M | Nasdaq Global Select Market,SPB | USA |
 |
Neogen Corporation
NEOG
|
$ 12.45 | 2.85 % | $ 2.71 B | Nasdaq Global Select Market,SPB | USA |
 |
Precipio
PRPO
|
$ 19.64 | 5.48 % | $ 31.5 M | Nasdaq Global Select Market | USA |
 |
Personalis
PSNL
|
$ 15.8 | 0.29 % | $ 1.41 B | Nasdaq Global Select Market | USA |
 |
Quidel Corporation
QDEL
|
$ 14.52 | 3.05 % | $ 612 M | Nasdaq Global Select Market,SPB | USA |
 |
VolitionRx Limited
VNRX
|
$ 0.2 | 5.65 % | $ 25.2 M | NYSE American |  Singapore |
 |
Centogene N.V.
CNTG
|
- | -6.23 % | $ 30.6 M | Nasdaq Global Market |  Germany |
 |
Trinity Biotech plc
TRIB
|
$ 6.43 | -2.02 % | $ 2.31 B | Nasdaq Global Select Market | Irlanda |
 |
Global Cord Blood Corporation
CO
|
- | - | $ 399 M | NYSE | China |
 |
Genetic Technologies Limited
GENE
|
- | - | $ 7.1 B | Nasdaq Capital Market |  Australia |
 |
Genetron Holdings Limited
GTH
|
- | 0.12 % | $ 80.1 M | Nasdaq Global Market | China |
 |
Aspira Women's Health
AWH
|
- | -6.19 % | $ 10.5 M | Nasdaq Capital Market,SPB | USA |
 |
Check-Cap Ltd.
CHEK
|
- | - | $ 9.42 M | Nasdaq Capital Market | Israel |
 |
Exact Sciences Corporation
EXAS
|
- | - | $ 19.8 B | Nasdaq Capital Market,SPB | USA |
 |
National Research Corporation
NRC
|
$ 27.03 | 12.3 % | $ 605 M | Nasdaq Global Select Market | USA |
 |
Twist Bioscience Corporation
TWST
|
$ 142.53 | 1.59 % | $ 8.52 B | Nasdaq Global Select Market,SPB | USA |
 |
Organovo Holdings
ONVO
|
- | -2.3 % | $ 19.4 M | Nasdaq Capital Market | USA |
 |
OpGen
OPGN
|
- | -16.95 % | $ 1.54 M | Nasdaq Capital Market | USA |
 |
PerkinElmer
PKI
|
- | -0.91 % | $ 14.7 B | NYSE,SPB | USA |
 |
Soleno Therapeutics
SLNO
|
- | - | $ 2.69 B | Nasdaq Capital Market | USA |
 |
Enzo Biochem
ENZ
|
- | -8.98 % | $ 14.8 K | NYSE | USA |
 |
Guardant Health
GH
|
$ 171.03 | -2.27 % | $ 21.4 B | Nasdaq Global Select Market,SPB | USA |
 |
Accelerate Diagnostics
AXDX
|
- | -61.36 % | $ 2.46 M | Nasdaq Global Select Market | USA |
 |
Interpace Biosciences
IDXG
|
$ 5.72 | 5.1 % | $ 25.3 M | Nasdaq Global Select Market | USA |
 |
Celcuity
CELC
|
$ 69.03 | -0.73 % | $ 3.23 B | Nasdaq Global Select Market | USA |
 |
Laboratory Corporation of America Holdings
LH
|
$ 367.96 | 3.97 % | $ 30.6 B | NYSE,SPB | USA |
 |
Medpace Holdings
MEDP
|
$ 656.33 | -1.08 % | $ 18.9 B | Nasdaq Global Select Market,SPB | USA |
 |
Charles River Laboratories International
CRL
|
$ 332.3 | -5.56 % | $ 16.5 B | NYSE,SPB | USA |
 |
Mettler-Toledo International
MTD
|
$ 1 723.68 | 1.51 % | $ 35.5 B | NYSE,SPB |  Schweiz |
 |
Castle Biosciences
CSTL
|
$ 35.78 | 1.82 % | $ 1.04 B | Nasdaq Global Market,SPB | USA |
 |
T2 Biosystems
TTOO
|
- | -39.35 % | $ 313 K | Nasdaq Global Select Market | USA |
 |
Biocept
BIOC
|
- | -13.05 % | $ 7.29 M | Nasdaq Capital Market | USA |
 |
QIAGEN N.V.
QGEN
|
$ 50.86 | 0.95 % | $ 11 B | NYSE | Niderland |
|
Akumin
AKU
|
- | -17.87 % | $ 25.9 M | Nasdaq Capital Market |  Canada |
 |
Brainsway Ltd.
BWAY
|
$ 11.19 | 0.36 % | $ 380 M | Nasdaq Global Select Market | Israel |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.